ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Muscle Mass Measurement Is Objective and More Predictive of Expected Mortality Than Functional Status in High MELD Liver Transplant Recipients

    J. Nolte,1 S. Gordon Burroughs,1 D. Victor,1 C. Mobley,1 N. Yu,2 T. Hirase,1 A. Saharia,1 A. Rajaraman,1 L. Moore,1 A. Gaber,1 R. Ghobrial.1

    1Surgery, Houston Methodist Hospital, Houston, TX; 2Radiology, Houston Methodist Hospital, Houston, TX.

    Introduction: Calculations used to determine expected survival post-liver transplant (OLT) are in part based on pre-OLT functional status. Functional status is subjectively measured by Karnofsky…
  • 2015 American Transplant Congress

    Is Pretransplant Anti-A/B Antibody Removal Prerequisite for Successful ABO Incompatible Kidney Transplantation in Children?

    S. Shishido,1 T. Kawamura,1 Y. Hamasaki,2 Y. Takahashi,1 Y. Hyodo,1 Y. Itabashi,1 H. Nihei,1 T. Yonekura,1 Y. Inaba,2 Y. Yoshida,2 K. Sakai,1 A. Aikawa.1

    1Nephrology, Toho University, School of Medicine, Tokyo, Japan; 2Pediatric Nephrology, Too University, School of Medicine, Tokyo, Japan.

    Purpose: We have recently demonstrated that the long-term outcome of ABO incompatible living donor kidney transplantation (ABOiKT) in children was comparable to those of ABO…
  • 2015 American Transplant Congress

    Tracking T Cell Fate After Antithymocyte Globulin (ATG) Immunotherapy in Infant Heart Transplant (HTx) Patients

    S.-I. Wang,1,2 I. Larsen,1,2 S. Urschel,1,2 R. Chinnock,3 J. Rusch,3 L. West.1,2

    1Univ. of Alberta, Edmonton, Canada; 2Alberta Transplant Institute, Edmonton, Canada; 3Loma Linda Univ., Loma Linda.

    Polyclonal T cell depletion with ATG is a common induction therapy in adult and pediatric transplantation. In adults, T cell recovery post-ATG involves homeostatic proliferation…
  • 2015 American Transplant Congress

    Pre-Transplant Anti-LG3 Antibodies Enhance Allograft Dysfunction in Kidney Transplant Recipients With Delayed or Slow Graft Function

    H. Cardinal, M. Hénault-Rondeau, S. Morissette, K. Hamelin, M.-J. Hébert.

    CHUM Research Center, Montreal, Canada.

    Background: We have previously shown that autoantibodies to the LG3 fragment of perlecan enhance vascular damage in a murine model of vascular rejection, particularly when…
  • 2015 American Transplant Congress

    Post-Kidney Transplant Infections in Desensitized Patients Receiving Thymoglobulin or Daclizumab Induction: Results of a Randomized Clinical Trial

    B. Orandi,1 J. Locke,2 E. Kraus,3 B. Lonze,1 N. Desai,1 N. Dagher,1 N. Alachkar,3 C. Simpkins,4 F. Naqvi,3 D. Segev,1 R. Montgomery,1 R. Avery.3

    1Department of Surgery, Johns Hopkins University, Baltimore; 2Department of Surgery, University of Alabama--Birmingham, Birmingham; 3Department of Medicine, Johns Hopkins University, Baltimore; 4Department of Surgery, Dartmouth, Lebanon.

    Live donor kidney transplant recipients requiring desensitization for donor-specific antibody, who were enrolled in a single-center randomized trial of thymoglobulin vs. daclizumab induction, were evaluated…
  • 2015 American Transplant Congress

    Loss of RIPK3 and Caspase-8 Enhance Intrinsic Apoptosis in Tubular Epithelial Cell (TEC) Death and Contributes to Kidney Ischemia Reperfusion Injury (IRI)

    B. Sung,1 Y. Su,3 A. Lau,3 J. Jiang,3 A. Haig,2 D. Green,4 Z. Zhang,2 A. Jevnikar.1

    1Microbiology and Immunology, Western University, London, ON, Canada; 2Pathology, Western University, London, ON, Canada; 3Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, ON, Canada; 4St. Jude Children's Research Hospital, Memphis, TN.

    [Background] Ischemia-reperfusion injury (IRI), a complex limiting factor in organ transplant survival, is related to multiple death pathways. Eliminating the key necroptotic molecule (RIPK3) improves…
  • 2015 American Transplant Congress

    Outpatient Management of Delayed Graft Function (DGF) Is Associated With Reduced Length of Stay and Acute Rejection

    B. Muth,1 B. Astor,1 J. Turk,1 M. Mohamed,1 S. Parajuli,1 D. Kaufman,2 D. Mandelbrot,1 A. Djamali.1,2

    1Department of Medicine, University of Wisconsin, Madison, WI; 2Department of Surgery, University of Wisconsin, Madison, WI.

    Delayed graft function (DGF) increases hospital length of stay (LOS) and risk for readmission, rejection, early graft loss and death. We created a multidisciplinary DGF…
  • 2015 American Transplant Congress

    Safety and Efficacy of All Oral DAA Therapy for Genotype 1 HCV Post-Liver Transplant: Interval Results from the HCV-TARGET Multicenter Prospective Observational Study

    J. O'Leary,1 R. Brown,2 K. Reddy,3 A. Kuo,4 G. Morelli,5 R. Stravitz,6 G. Everson,7 C. Durand,8 H. Vargas,9 P. Kwo,10 C. Frenette,11 J. Peter,12 M. Vainorius,12 L. Akushevich,12 D. Nelson,5 M. Fried,12 N. Terrault.13

    1Baylor University Medical Center, TX; 2Columbia University, NY; 3University of Pennsylvania, PA; 4UCSD, CA; 5University of Florida, Gainesville, Gainesville, FL; 6Virginia Commonwealth University, VA; 7University of Colorado, CO; 8Johns Hopkins, MD; 9Mayo Clinic, AZ; 10Indiana University, IL; 11Scipps Clinic, CA; 12University of North Carolina, NC; 13UCSF, CA.

    The safety and efficacy of direct-acting antivirals (DAA) for HCV post-LT remain unknown. METHODS: We describe the safety and efficacy of all oral DAA-therapy for…
  • 2015 American Transplant Congress

    Six Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients

    J. Leventhal, M. Abecassis, L. Gallon, J. Galvin, J. Mehta, K. Ravindra, D. Tollerud, M. Elliott, S. Ildstad.

    Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL; Duke University, Durham, NC; Institute for Cellular Therapeutics, University of Louisville, Louisville, KY; Regenerex, LLC, Louisville, KY.

    27 subjects have been transplanted in a phase 2 protocol (IDE 13947) based upon tolerogenic CD8+/TCR- facilitating cells (FCRx) and 200 cGy TBI-based nonmyeloablative conditioning…
  • 2015 American Transplant Congress

    Hepatic Stellate Cells Directly Inhibit B Cells Via PD-L1

    Y. Li, K. Fang, S. Qian, J. Fung, L. Lu, F. Lin.

    Immunology, Lerner Research Institute; 2General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

    Hepatic stellate cells (HSCs) account for one third of the nonparenchymal cells in the liver, which are considered to be critical in maintaining the immunoprivileged…
  • 1
  • 2
  • 3
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences